Archives of cardiovascular diseases
-
Arch Cardiovasc Dis · May 2018
Multicenter Study Comparative StudyApixaban in the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation in France: Rationale and design of the PAROS cross-sectional study.
Atrial fibrillation (AF) is the most common arrhythmia worldwide, and its prevalence is expected to increase with population ageing. The use of vitamin K antagonists (VKAs) for the prevention of stroke and/or systemic embolism in patients with non-valvular atrial fibrillation (NVAF) was recently challenged by non-VKA oral anticoagulants (NOACs), demonstrating a favourable risk-benefit profile, with reductions in stroke, intracranial haemorrhage and mortality, similar major bleeding, but increased gastrointestinal bleeding. Nevertheless, data on their use in a "real-life" setting are scarce for France. ⋯ The PAROS study will provide real-life data on the characteristics of NVAF patients and their anticoagulant prescription in France.
-
Arch Cardiovasc Dis · May 2018
Electrical storm in the early phase of HeartMate® II device implantation: Incidence, risk factors and prognosis.
Ventricular arrhythmia is common after left ventricular assist device (LVAD) implantation, especially in the early postoperative phase (<30 days). ⋯ ES is a common and pejorative feature in the early postoperative period.